BUY 3,4-MD-PCMo ONLINE
Like other members of the 3,4-MD- group, this compound has shown a much higher affinity for the NMDA receptors than other receptors, such as the dopamine, serotonin, and norepinephrine transporters. While the impacts of this remain inconclusive, it’s believed this effect gives this group of drugs a particularly strong dissociative quality and less euphoric, stimulant, and crossover effects than other arylcyclohexylamines. 3′,4′-MD-PCMo
“3,4-MD-PCMo” appears to be a shorthand for a chemical compound, likely in the context of substituted amphetamines or research chemicals, possibly derived from or analogous to MDMA (3,4-methylenedioxymethamphetamine).
Here’s a breakdown of the name:
- 3,4-MD likely stands for 3,4-methylenedioxy, a common substitution pattern on the phenyl ring found in compounds like MDMA.
- PCMo is not a standard abbreviation, but it may refer to a phenylcyclohexylmorpholine-like or piperazine/cathinone/morpholine structure, depending on the context. However, “PCMo” is ambiguous and not widely recognized in established chemical literature.
It’s possible this is:
- A designer drug or research chemical name, using a non-standard abbreviation.
- A novel psychoactive substance (NPS).
- A mislabeling or an error in the naming.
Could you clarify where you encountered “3,4-MD-PCMo”? Is it from a scientific paper, a website, or a specific context like pharmacology or recreational drug forums?
With that said, the 3,4-MD-PCMo has the lowest activity at the NMDA receptors of the 3,4-MD group at 425 nM (Ki). Comparatively, the binding affinity for related compounds is 62.8 nM (3,4-MD-PCP), 24.8 nM (3,4-MD-PCPr), and 35.5 nM (3,4-MD-PCE). The lower the number, the stronger a compound’s affinity for specific receptors. Buy 3′,4′-MD-PCMo powder
3,4-MD-PCMo Specs:
| Chemical Name | 3,4-methylenedioxy-cyclohexylmorpholine |
| Status | Research Chemical |
| Duration of Effects | Unknown |
| Estimated Threshold Dose | 4 mg |
| Common Dose | 5–40 mg |
| PubChem ID | Not Available |
| CAS# | Not Available |
Reviews
There are no reviews yet.